Experimental justification of the use of benzimidazole derivatives as antiasthenic agents after craniocerebral trauma
Zarubina, I.V.; Nurmanbetova, F.N.; Shabanov, P.D.
Eksperimental'naia i Klinicheskaia Farmakologiia 68(3): 46-49
2005
ISSN/ISBN: 0869-2092 PMID: 16047681 Document Number: 589640
Experimental administration of benzimidazole derivatives upon model cranioccrebral trauma favored rapid normalization of the behavior of hypoxia-sensitive animals and prevented from excess activation of lipid peroxidation processes in the brain. It is recommended to use benzimidazole derivatives for the control of free-radical processes and the correction of psychopathologic disorders in cases of post-trauma cerebroasthenia.